Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

Vinpocetine

Generic Name: Vinpocetine

Drug Type: Small Molecule

Chemical Formula: C_₂₂H_₂₆N_₂O_₂

CAS Number: 42971-09-5

Unique Ingredient Identifier: 543512OBTC

Overview

Vinpocetine has been investigated for the treatment of Epilepsy.

Background

Vinpocetine has been investigated for the treatment of Epilepsy.

Indication

用于改善脑出血、脑梗死及脑动脉粥样硬化所致的多种神经或精神症状，如眩晕、头痛、记忆力减退、行为障碍、精神不振、抑郁、四肢麻木、语言障碍等。

Associated Conditions

Cerebrovascular stenosis
Neurological Disorders

Clinical Trials

Dose Escalation Study of Vinpocetine in Healthy Volunteers

Phase 1

Not yet recruiting

Posted: 2024/10/10

Sponsor:Stanford University

ID:NCT06635746

Clinical Outcome of Vinpocetine in Diabetic Nephropathy

Phase 2

Recruiting

Posted: 2024/06/04

Sponsor:Ain Shams University

ID:NCT06441591

Vinpocetine Inhibits NF-κB-dependent Inflammation in Acute Ischemic Stroke Patients

Phase 2

Completed

Posted: 2016/08/25

Sponsor:Tianjin Medical Univ...

ID:NCT02878772

Cognitive Effects of Vinpocetine in Healthy Adults and Patients With Epilepsy

Phase 1

Suspended

Posted: 2013/12/16

Sponsor:Stanford University

ID:NCT02011971

FDA Approved Products

No FDA products found for this drug

Singapore Approved Products

CAVINTON TABLET 5 mg

Manufacturer:CHEMICAL WORKS OF GEDEON RICHTER PLC

Form:TABLET

Strength:5 mg

Online:Yes

Approved: 1988/04/26

Approval:SIN00396P

Related News

No news found

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

Home Terms & Conditions Privacy Policy